Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers
Dogster
Learn More →
In the News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans
Biopharma Boardroom
Learn More →
Scientific Publications
A study on the relationship between MDR1 mutation and ex vivo drug sensitivities of canine lymphomas
Biotechnology and Bioprocess Engineering
Learn More →
Video/Podcast Interviews
Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans
The Bio Report
Learn More →
In the News
From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology
Pharmacy Times
Learn More →
Scientific Publications
Recent advances in and applications of ex vivo drug sensitivity analysis for blood cancers
Blood Research
Learn More →
Presentations
Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics
Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
Decoding Feline Lymphoma: From Diagnosis to Prognosis
Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning
Veterinary Cancer Society Annual Conference 2024
Learn More →
Press Releases
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans
Business Wire
Learn More →
In the News
ImpriMed unveils cancer treatment forecast technology
MobiHealthNews
Learn More →
In the News
New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma
American Animal Hospital Association NEWStat®
Learn More →
Video/Podcast Interviews
From Dogs to Humans: The Power of Precision Medicine with Dr. Lim
Target Cancer Podcast
Learn More →
In the News
Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences
Veterinary Practice
Learn More →
In the News
Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma
DVM360
Learn More →
Press Releases
ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences
Business Wire
Learn More →
Presentations
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning
ASCO Breakthrough 2024
Learn More →
Scientific Publications
Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas
Veterinary Sciences
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
